DNA RNA and Cells

04 Feb 2009 OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer
03 Feb 2009 Senesco Announces Results of Pre-Clinical Efficacy, Toxicology and Dose Ranging Studies for Multiple Myeloma Therapeutic Candidate
03 Feb 2009 Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
03 Feb 2009 Medgenics Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease
02 Feb 2009 Idera Pharmaceuticals Announces Achievement of Clinical Milestone Under its Collaboration with Merck KGaA for Cancer Treatment
02 Feb 2009 Aastrom Phase II IMPACT-DCM Clinical Trial Placed On Clinical Hold Pending Review of Isolated Serious Adverse Event Related to Anesthesia Management in One Patient
02 Feb 2009 Cenix BioScience Signs Research Agreement with Boehringer Ingelheim for RNAi-Based Target Discovery
30 Jan 2009 First Patient Treated in Adipose Stem & Regenerative Cell Study for Stress Urinary Incontinence
29 Jan 2009 Glybera(R) Lowers Pancreatitis Incidence Significantly
23 Jan 2009 Geron Receives FDA Clearance to Begin Worlds First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
23 Jan 2009 Alnylam Receives Clearance from FDA to Initiate Phase I Study with ALN-VSP for the Treatment of Liver Cancers
22 Jan 2009 Gentium Announces Completion of Enrollment for the Phase II/III European Pediatric Prevention Trial of Defibrotide
21 Jan 2009 Neurologix Commences its Phase 2 Clinical Trial of Novel Gene Transfer Approach for Treatment of Parkinsons Disease
21 Jan 2009 AVI BioPharma Announces Successful Clinical Trial of AVI-4658 for Treatment of Duchenne Muscular Dystrophy by Exon Skipping
21 Jan 2009 ReNeuron gains UK regulatory approval to start ground-breaking clinical trial with stem cell therapy for stroke
20 Jan 2009 Opexa Provides Update on Various Corporate Developments
15 Jan 2009 Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product
14 Jan 2009 USA FDA Allows BioCancell to Commence Phase I/IIa Ovarian and Pancreatic Clinical Trials
13 Jan 2009 Pluristem Therapeutics Files an IND Application with the FDA to Initiate a Phase I Clinical Trial Utilizing PLX-PAD for Critical Limb Ischemia
13 Jan 2009 International Stem Cell Begins Pre-Clinical Testing of Its Parthenogenetic Stem Cells for Treatment of Retinal Disease
12 Jan 2009 Genzyme and Isis Begin New Clinical Trials of Mipomersen
09 Jan 2009 Alnylam and Cubist Form Strategic Collaboration to Develop and Commercialize RNAi Therapeutics Targeting Respiratory Syncytial Virus (RSV) Infection
08 Jan 2009 Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer
08 Jan 2009 Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
08 Jan 2009 TOPIGEN Pharmaceuticals Reports Phase 2 Results of TPI ASM8 in Asthma Patients

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up